Literature DB >> 14565635

Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm.

Ramazan Atak1, Ertan Yetkin, Ozkan Yetkin, Selime Ayaz, Mehmet Ileri, Kubilay Senen, Hasan Turhan, Ali Riza Erbay, Sengül Cehreli.   

Abstract

A hypercoagulable state has been reported in patients with mitral stenosis (MS) and sinus rhythm (SR). However it has been suggested that the coagulation activity may be increased only within the left atrium in MS, with normal peripheral blood levels. The aim of the present study was to assess regional left atrial and systemic coagulation activities by measuring PF1+2 in patients with severe mitral stenosis and sinus rhythm, normal blood clotting times, and no left atrial thrombus. The study was conducted in 25 consecutive patients with moderate-to-severe MS and sinus rhythm who underwent percutaneous balloon mitral valvuloplasty. Transesophageal echocardiography was performed before the valvuloplasty procedure in all patients to exclude the presence of left atrial thrombus and left atrial spontaneous echo contrast (LASEC). There were no statistically significant differences between LASEC-positive and LASEC-negative patients with respect to age, gender, fibrinogen levels, prothrombin time, mitral valve area, mean mitral gradient, pulmonary artery pressure (in all p > 0.05). Regional (left atrial) PF1+2 levels of both LASEC-positive and LASEC-negative patients were significantly elevated when compared to control subjects (p < 0.01). Statistically significant elevated systemic level of PF1+2 was observed only in LASEC-positive patients when compared to control subjects (p < 0.01, p > 0.05, respectively). In conclusion patients with severe mitral stenosis and SR have increased regional coagulation activity in both LASEC-negative and LASEC-positive groups. Although this increased regional coagulation activity has been reflected in peripheral blood of LASEC-positive patients, it has not been reflected in peripheral blood of LASEC-negative patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565635     DOI: 10.1177/000331970305400509

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

1.  Thrombophilia in ischemic stroke subtypes: implications for treatment.

Authors:  Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation--A pilot study.

Authors:  Jamal Yusuf; Mayank Goyal; Saibal Mukhopadhyay; Vimal Mehta; Sunil Dhaiya; Renu Saxena; Vijay Trehan
Journal:  Indian Heart J       Date:  2015-11-23

3.  Mitral stenosis presenting with acute hearing loss.

Authors:  Chamutal Gur; Gadi Lalazar; Guy Raphaeli; Dan Gilon; Eldad Ben-Chetrit
Journal:  PLoS Med       Date:  2006-06-27       Impact factor: 11.069

4.  Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma.

Authors:  Istemihan Tengiz; Ertugrul Ercan; Fahri Sahin; Emin Alioglu; Can Duman; Guray Saydam; Filiz Buyukkececi
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.